1Cellbio

1Cellbio is a United States life-science company headquartered in Watertown, Massachusetts. It operates in the single-cell analysis and cell-encapsulation space, a segment of the life-science tools industry that serves academic research laboratories, biopharmaceutical companies, and clinical research organizations. The company is associated with microfluidic and droplet-based technologies that allow individual cells to be isolated, encapsulated, and analyzed at high throughput, a capability that has become central to genomics, transcriptomics, drug discovery, and cell-therapy development. As a privately held enterprise, 1Cellbio is not listed on a public stock exchange and does not report quarterly earnings publicly. Its commercial identity is built around providing instruments, consumables, and supporting software or services that enable researchers to study cell-to-cell heterogeneity rather than bulk population averages. This positioning places it alongside other single-cell and microfluidics platform providers in a rapidly evolving market. The company's official web presence is at 1cell-bio.com, where it presents its product and technology offerings. Its headquarters location in Watertown places it within the Greater Boston life-science cluster, one of the world's densest concentrations of biotechnology research institutions, pharmaceutical companies, and venture-backed startups. Because 1Cellbio is a relatively specialized and privately held company, detailed public information about its founding date, founders, ownership structure, and financial history is limited. The available evidence confirms its identity as a company based in Watertown, United States, and its focus on cell-based biotechnology tools. Any further specifics regarding funding rounds, product model names, or executive leadership should be verified against primary company sources before being treated as established fact.

1Cellbio is a life-science company based in Watertown, Massachusetts, in the United States. Public evidence identifies it as a company operating in the Watertown area, within the Greater Boston biotechnology and life-science cluster. The company is associated with the development of single-cell analysis and cell-encapsulation technologies, a field that grew rapidly from the 2000s onward as microfluidics and droplet-based methods made it possible to isolate and study individual cells at scale. The broader single-cell technology sector emerged from advances in microfluidics, molecular biology, and computational analysis. Companies in this space typically develop instruments and consumables that encapsulate single cells in droplets or microwells, enabling genomic, transcriptomic, and proteomic measurements at single-cell resolution. 1Cellbio's positioning in Watertown places it within a regional ecosystem that includes major research universities, hospitals, and biopharma companies, providing both a talent pool and a customer base. Specific details of 1Cellbio's corporate history — such as its exact founding date, founding team, funding history, and product launch timeline — are not established by the available evidence. The company maintains an official website at 1cell-bio.com. As a privately held company, it does not publish financial statements or trade on a public exchange. Its history should therefore be understood primarily through its technology focus and market positioning rather than through a detailed public corporate record.

A specialized life-science tools provider focused on single-cell and cell-encapsulation technologies for research and clinical markets.

Product categories. Single-cell analysis platforms · Cell encapsulation systems · Microfluidic instruments and consumables

1. 1Wikidata: 1Cellbio (United States)wikidata.org
2. 21Cellbio official website1cell-bio.com